Omthera Pharmaceuticals, Inc.

90 Washington Valley Rd.,,
Bedminster Township, New Jersey 07921
United States,
(908)741-4399
www.omthera.com

Omthera Pharmaceuticals, Inc. is an emerging specialty pharmaceuticals company focusing its efforts on the clinical development of new therapies for dyslipidemia. Led by a team of experts with exceptional experience in developing new therapies for lipid disorders, Omthera is dedicated to developing innovative therapies for the millions of patients who have elevated triglyceride levels and increased risk of cardiovascular disease.

Omthera Pharmaceuticals was acquired by AstraZeneca on July 18, 2013.

Join Mergr to view all 177 acquisitions of life science companies in 2013, including 20 acquisitions by private equity firms, and 157 by strategics.

Out of 60 sectors in the Mergr database, life science ranked 10 in number of deals in 2013. The largest life science acquisition in 2013 was Onyx Pharmaceuticals - which was acquired by Amgen for $10.4B.

Join Mergr to view this profile - and discover more life science acquisitions of companies like Omthera Pharmaceuticals.


What's Mergr?

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 3.1K Private Equity Firms
  • 110K M&A Transactions
  • 120K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 2.7K M&A Advisors
    (Investment Banks and Law Firms)
  • 38K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.